Silence Therapeutics plc
SLN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001479615
No open-market purchases or sales by Silence Therapeutics plc insiders were filed in the last 90 days; 72 institutions reported holding it in 13F filings for Q2 2026, worth $236.2M in total; no superinvestor holds it.
Other share classesSLNCF
Superinvestors holding SLN, Q2 2026
No superinvestor reported holding SLN in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of SLN each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q4 2024
0 superinvestors holding at quarter end
- Sold out
- Duquesne Family Office
Q1 2024
1 superinvestor holding at quarter end